Inventor
KANNAN GUNASEKARAN
US41 patents
⚠️ This page may combine multiple inventors who share the name “KANNAN GUNASEKARAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
33 patentsUS9546203B2Jan 17, 2017
Aglycosylated Fc-containing polypeptides with cysteine substitutions
AMGEN INC34 citations98
US9580486B2Feb 28, 2017
Interleukin-2 muteins for the expansion of T-regulatory cells
AMGEN INC47 citations96
US9243058B2Jan 26, 2016
BCMA antigen binding proteins
AMGEN INC83 citations96
US10093711B2Oct 9, 2018
Interleukin-2 muteins for the expansion of T-regulatory cells
AMGEN INC25 citations94
US9932380B2Apr 3, 2018
Interleukin-2 muteins for the expansion of T-regulatory cells
AMGEN INC23 citations93
US9862752B2Jan 9, 2018
Growth differentiation factor 15 (GDF-15) constructs
AMGEN INC16 citations91
US9714276B2Jul 25, 2017
Growth differentiation factor 15 (GDF-15) polypeptides
AMGEN INC17 citations91
US10851144B2Dec 1, 2020
Interleukin-2 muteins for the expansion of T-regulatory cells
AMGEN INC16 citations89
US10562950B2Feb 18, 2020
Interleukin-2 muteins for the expansion of T-regulatory cells
AMGEN INC5 citations84
US10220090B2Mar 5, 2019
BCMA Antigen binding proteins
AMGEN INC15 citations84
US10829535B2Nov 10, 2020
Interleukin-2 muteins for the expansion of T-regulatory cells
AMGEN INC5 citations83
US10336798B2Jul 2, 2019
Growth differentiation factor 15 (GDF-15) polypeptides
AMGEN INC9 citations83
US10233237B2Mar 19, 2019
Heterodimeric immunoglobulins
AMGEN INC8 citations83
US9822173B2Nov 21, 2017
Heterodimeric immunoglobulins
AMGEN INC10 citations83
US9458246B2Oct 4, 2016
Proteins specific for BAFF and B7RP1
AMGEN INC8 citations83
US11541103B2Jan 3, 2023
Interleukin-21 mutein/ anti-PD-1 antibody conjugates
AMGEN INC7 citations82
US10465009B2Nov 5, 2019
BCMA antigen binding proteins
AMGEN INC9 citations81
US11739131B2Aug 29, 2023
Growth differentiation factor 15 (GDF-15) polypeptides
AMGEN INC1 citations72
US10934362B2Mar 2, 2021
Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof
AMGEN INC5 citations72
US10421823B2Sep 24, 2019
Proteins specific for BAFF and B7RP1 and uses thereof
AMGEN INC2 citations72
US11492417B2Nov 8, 2022
Proteins specific for BAFF and B7RP1 and uses thereof
AMGEN INC2 citations71
US10894814B2Jan 19, 2021
Growth differentiation factor 15 (GDF-15) constructs
AMGEN INC4 citations71
US10421824B2Sep 24, 2019
Proteins specific for BAFF and B7RP1
AMGEN INC2 citations71
US11104745B2Aug 31, 2021
Anti-TL1A/anti-TNF-alpha bispecific antigen binding proteins and uses thereof
AMGEN INC5 citations70
US11518808B2Dec 6, 2022
Anti-PD-1 antibodies and methods of treatment
AMGEN INC5 citations68
US11198732B2Dec 14, 2021
Fc variants
AMGEN INC1 citations63
US11466078B2Oct 11, 2022
Heterodimeric immunoglobulins
AMGEN INC0 citations62
US11919964B2Mar 5, 2024
Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof
AMGEN INC0 citations61
US11248052B2Feb 15, 2022
Antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor
AMGEN INC1 citations61
US12552877B2Feb 17, 2026
Anti-TL1A antibodies and uses thereof
AMGEN INC0 citations59
US12479930B2Nov 25, 2025
Proteins specific for BAFF and B7RP1 and uses thereof
AMGEN INC0 citations59
US11976103B2May 7, 2024
Interleukin-2 muteins for the expansion of T-regulatory cells
AMGEN INC0 citations58
US11976102B2May 7, 2024
Interleukin-2 muteins for the expansion of T-regulatory cells
AMGEN INC0 citations57
KANNAN GUNASEKARAN
3 patentsUS8592562B2Nov 26, 2013
Method for making antibody Fc-heterodimeric molecules using electrostatic steering effects
KANNAN GUNASEKARAN339 citations96
US9200060B2Dec 1, 2015
Monomeric antibody Fc
KANNAN GUNASEKARAN46 citations92
US9308258B2Apr 12, 2016
Stable and aggregation free antibody FC molecules through CH3 domain interface engineering
KANNAN GUNASEKARAN13 citations82